• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上腔静脉重建的假体选择:中期通畅率比较

Prosthesis selection for reconstruction of superior vena cava: comparison of midterm patency rates.

作者信息

Cho Han, Sohn Suk Ho, Choi Jae Woong, Hwang Ho Young, Kim Kyung Hwan, Na Kwon Joong, Kang Chang Hyun

机构信息

Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Interdiscip Cardiovasc Thorac Surg. 2024 Dec 3;39(6). doi: 10.1093/icvts/ivae194.

DOI:10.1093/icvts/ivae194
PMID:39589858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11852341/
Abstract

OBJECTIVES

This study compared the mid-term patency of expanded polytetrafluoroethylene grafts without rings versus that of bovine pericardial conduits used for superior vena cava reconstruction for various thoracic diseases.

METHODS

Among 80 patients who underwent superior vena cava resection and reconstruction between 2009 and 2023 at our institution, 31 patients who received polytetrafluoroethylene grafts without rings (Polytetrafluoroethylene group) and 28 patients who received bovine pericardial conduits (Bovine group) were enrolled. Median follow-up durations were 19.5 and 64.6 months in the Polytetrafluoroethylene and Bovine groups, respectively. Primary outcome was midterm graft patency rate, and secondary outcomes were early and midterm clinical outcomes, including all-cause mortality and superior vena cava reintervention.

RESULTS

Operative mortality was 1.7%. Cumulative incidence of all-cause mortality was not significantly different between the groups. Graft occlusion was detected in 22 patients. Cumulative incidence of graft occlusion was 24.2%, 36.4%, 42.4%, 48.5% and 60.6% at 1 month, 3 months, 6 months, 1 year and 2 years, respectively, in the Bovine group, whereas no graft occlusion was observed in the Polytetrafluoroethylene group (P = 0.007). Although the incidence of graft occlusion was higher in the Bovine group, cumulative incidence of reintervention was not significantly different between the groups (0.0% vs 3.0% in Polytetrafluoroethylene vs Bovine groups at 1 year, P = 0.406). Multivariate analysis demonstrated that bovine pericardial conduit (polytetrafluoroethylene graft as reference) and left brachiocephalic vein reconstruction (right brachiocephalic vein reconstruction as reference) were significant risk factors for graft occlusion.

CONCLUSIONS

In superior vena cava reconstruction, polytetrafluoroethylene grafts without rings were superior to bovine pericardial conduits in terms of midterm graft patency.

摘要

目的

本研究比较了无环膨体聚四氟乙烯移植物与用于各种胸科疾病上腔静脉重建的牛心包管道的中期通畅率。

方法

在2009年至2023年期间于我院接受上腔静脉切除和重建的80例患者中,纳入了31例接受无环聚四氟乙烯移植物的患者(聚四氟乙烯组)和28例接受牛心包管道的患者(牛心包组)。聚四氟乙烯组和牛心包组的中位随访时间分别为19.5个月和64.6个月。主要结局是中期移植物通畅率,次要结局是早期和中期临床结局,包括全因死亡率和上腔静脉再次干预。

结果

手术死亡率为1.7%。两组间全因死亡率的累积发生率无显著差异。在22例患者中检测到移植物闭塞。牛心包组在1个月、3个月、6个月、1年和2年时移植物闭塞的累积发生率分别为24.2%、36.4%、42.4%、48.5%和60.6%,而聚四氟乙烯组未观察到移植物闭塞(P = 0.007)。尽管牛心包组移植物闭塞的发生率较高,但两组间再次干预的累积发生率无显著差异(聚四氟乙烯组与牛心包组在1年时分别为0.0%和3.0%,P = 0.406)。多因素分析表明,牛心包管道(以聚四氟乙烯移植物为对照)和左头臂静脉重建(以右头臂静脉重建为对照)是移植物闭塞的显著危险因素。

结论

在上腔静脉重建中,无环聚四氟乙烯移植物在中期移植物通畅方面优于牛心包管道。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/35159e11d0f6/ivae194f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/9143003a6826/ivae194f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/5cb07f070672/ivae194f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/f0bc96de4747/ivae194f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/72087b2e3155/ivae194f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/35159e11d0f6/ivae194f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/9143003a6826/ivae194f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/5cb07f070672/ivae194f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/f0bc96de4747/ivae194f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/72087b2e3155/ivae194f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4ec/11852341/35159e11d0f6/ivae194f4.jpg

相似文献

1
Prosthesis selection for reconstruction of superior vena cava: comparison of midterm patency rates.上腔静脉重建的假体选择:中期通畅率比较
Interdiscip Cardiovasc Thorac Surg. 2024 Dec 3;39(6). doi: 10.1093/icvts/ivae194.
2
Long-term graft patency after replacement of the brachiocephalic veins combined with resection of mediastinal tumors.头臂静脉置换联合纵隔肿瘤切除术后的长期移植血管通畅情况。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):809-12. doi: 10.1016/j.jtcvs.2004.05.001.
3
Reconstruction of the vena cava and of its primary tributaries: a preliminary report.腔静脉及其主要分支的重建:初步报告。
J Vasc Surg. 1990 Mar;11(3):373-81. doi: 10.1067/mva.1990.16343.
4
Prosthetic replacement of the superior vena cava with a custom-made pericardial graft: an experimental study.使用定制心包移植物进行上腔静脉的人工置换:一项实验研究。
Can J Surg. 1992 Jun;35(3):305-9.
5
Reconstruction of the superior vena cava: benefits of postoperative surveillance and secondary endovascular interventions.上腔静脉重建:术后监测及二次血管内介入治疗的益处
J Vasc Surg. 1998 Feb;27(2):287-99; 300-1. doi: 10.1016/s0741-5214(98)70359-3.
6
Surgical outcomes after superior vena cava reconstruction with expanded polytetrafluoroethylene grafts.使用膨体聚四氟乙烯移植物进行上腔静脉重建后的手术结果。
Ann Thorac Cardiovasc Surg. 2014;20(4):310-5. doi: 10.5761/atcs.oa.13-00050. Epub 2013 Jun 4.
7
Results of superior vena cava reconstruction with externally stented-polytetrafluoroethylene vascular prostheses.体外支架聚四氟乙烯血管移植物重建上腔静脉的结果。
Ann Thorac Surg. 2010 Aug;90(2):383-7. doi: 10.1016/j.athoracsur.2010.04.004.
8
Long Term Results of Bypass Graft to the Right Atrium in the Management of Superior Vena Cava Syndrome in Dialysis Patients.长期结果旁路移植到右心房在上腔静脉综合征管理透析患者。
Ann Vasc Surg. 2021 Jul;74:321-329. doi: 10.1016/j.avsg.2021.01.099. Epub 2021 Mar 6.
9
Early Cannulation of Bovine Carotid Artery Graft Reduces Tunneled Dialysis Catheter-Related Complications: A Comparison of Bovine Carotid Artery Graft Versus Expanded Polytetrafluoroethylene Grafts in Hemodialysis Access.早期对牛颈动脉移植物进行插管可减少隧道式透析导管相关并发症:牛颈动脉移植物与膨体聚四氟乙烯移植物在血液透析通路中的比较
Vasc Endovascular Surg. 2019 Feb;53(2):104-111. doi: 10.1177/1538574418813595. Epub 2018 Nov 29.
10
Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.上腔静脉人工血管置换联合纵隔-肺恶性肿瘤切除术后的长期随访
J Thorac Cardiovasc Surg. 1991 Aug;102(2):259-65.

本文引用的文献

1
Superior Vena Cava Reconstruction in Masaoka Stage III and IVa Thymic Epithelial Tumors.胸腺癌 Masaoka Ⅲ期和Ⅳa 期患者的上腔静脉重建。
Ann Thorac Surg. 2022 Jun;113(6):1882-1890. doi: 10.1016/j.athoracsur.2021.05.077. Epub 2021 Jun 27.
2
Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences.心血管疾病患者血栓形成倾向的种族差异:解释预后差异的潘多拉魔盒。
Korean Circ J. 2021 Mar;51(3):202-221. doi: 10.4070/kcj.2020.0537.
3
The change of therapeutic trends in the thymic epithelial tumor.
胸腺上皮性肿瘤治疗趋势的变化
J Thorac Dis. 2019 Dec;11(12):5652-5654. doi: 10.21037/jtd.2019.11.15.
4
Prosthetic Reconstruction of Superior Vena Cava System for Thymic Tumor: A Retrospective Analysis of 22 Cases.胸腺肿瘤患者上腔静脉系统人造血管重建:22 例回顾性分析。
Thorac Cardiovasc Surg. 2021 Mar;69(2):165-172. doi: 10.1055/s-0039-3401044. Epub 2020 Jan 31.
5
Superior Vena Cava Replacement for Thymic Malignancies.上腔静脉置换治疗胸腺癌。
Ann Thorac Surg. 2019 Feb;107(2):386-392. doi: 10.1016/j.athoracsur.2018.08.060. Epub 2018 Oct 11.
6
Superior vena cava replacement combined with venovenous shunt for lung cancer and thymoma: a case series.上腔静脉置换联合静脉-静脉分流术治疗肺癌和胸腺瘤:病例系列
J Thorac Dis. 2018 Jan;10(1):363-370. doi: 10.21037/jtd.2017.12.130.
7
Temporary bypass for superior vena cava reconstruction with Anthron bypass tube.使用Anthron旁路管进行上腔静脉重建的临时旁路。
J Thorac Dis. 2017 Jul;9(7):E614-E618. doi: 10.21037/jtd.2017.06.06.
8
Robotic Thymectomy in Anterior Mediastinal Mass: Propensity Score Matching Study With Transsternal Thymectomy.前纵隔肿物的机器人胸腺切除术:与经胸骨胸腺切除术的倾向评分匹配研究
Ann Thorac Surg. 2016 Sep;102(3):895-901. doi: 10.1016/j.athoracsur.2016.03.084. Epub 2016 May 25.
9
Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion.头臂静脉或上腔静脉人工血管置换联合恶性肿瘤切除:人工血管通畅情况及人工血管闭塞的危险因素
J Thorac Dis. 2016 Jan;8(1):61-7. doi: 10.3978/j.issn.2072-1439.2016.01.07.
10
Results of extracardiac conduit total cavopulmonary connection in 500 patients.500例患者心外管道全腔静脉肺动脉连接术的结果
Eur J Cardiothorac Surg. 2015 Dec;48(6):825-32; discussion 832. doi: 10.1093/ejcts/ezv072. Epub 2015 Mar 13.